Generic Drugs Market Research Report 2019, Industry Trends, Share, Size, Demand and Forecast By 2024

Global Generic Drugs Market Size, Share Expected to Reach US$ 474 Billion Till 2023

Copyright © IMARC Service Pvt Ltd. All Rights Reserved

About IMARC Group

Report Description

IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

Generic Drugs Market Report By Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology and Others), Drug Delivery (Oral, Injectables, Dermal/Topical and Inhalers), Distribution Channel, Region Market Overview: Generics drugs are bioequivalent versions of off-patented branded drugs with similar dosage, form, strength, quality, effect, intended use, side effects, and route of administration. Generic drugs are more affordable as they require lower capital investments as compared to their branded counterparts.

Over the past few years, there has been a rise in the prevalence of chronic diseases including cardiovascular diseases, diabetes, Alzheimer’s disease, Parkinson’s disease, etc. which has presented the generic drug manufacturers with ample growth opportunities. On the basis of volume, these drugs currently account for around 80% of the total drug prescriptions worldwide. According to IMARC Group, the global generic drug market reached a value of around US$ 315 Billion 2017.

Request Free a Copy Sample Generic Drug Market Report: https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample A number of branded drugs are expected to lose their patent protection in the upcoming years which is expected to improve the growth prospects of the market across the globe.

Report Description and Highlights

Report Description

The rising geriatric population, increasing awareness among the consumers, expanding insurance coverage and growing access to healthcare facilities are some of the other factors which are supporting the global generics market growth. Despite the presence of a number of driving forces, the global generic drugs market faces some challenges as well, such as the negative perception of consumers regarding the effectiveness and safety of generic drugs. Looking forward, the generic drugs market size is expected to reach US$ 474 Billion by 2023, at a projected CAGR of nearly 7% during 2018-2023.

Breakup by Therapy Area The generic drug market has been segmented on the basis of different therapy areas including CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes and oncology. Amongst these, generic drugs are majorly used for treating diseases related to CNS (Central Nervous System). The CNS is made up of the nerves in the spinal cord and brain, and controls and processes most of the bodily functions. Generic medicines are generally available in the form of CNS depressants which are used for anxiety, sleep disorders and stress. Apart from this, they are also used for treating relapsing forms of multiple sclerosis as well as symptoms of Parkinson’s disease.

Breakup by Drug Delivery

Market Segmentation

Report Description

The generic drug market has been analysed on the basis of various drug delivery methods, such as oral, injectables, dermal/topical and inhalers. Presently, oral drugs represent the most popular segment as they are convenient for the patients and require minimal or no medical assistance. Oral generic drugs can be swallowed, chewed or placed under the tongue to dissolve. generic Injectable drugs, on the other hand, are gaining popularity as they can be directly infused into the bloodstream. Additionally, certain medicines do not have an effect if they are administered orally as the active ingredients get destroyed by the digestive enzymes, owing to which these medicines are produced in injectable forms.

Breakup by Distribution Channel Currently, there are two main distribution channels for the sales of generic drugs, namely, retail pharmacies and hospital pharmacies. At present, majority of generic drugs are sold through retail pharmacies. Apart from oral drugs, these stores also house injectables that can be administered without medical assistance, such as insulin. Retail pharmacies are easily accessible by the consumers as they are located at convenient locations. Moreover, an increase in the number of 24-hour pharmacies further supports the growth of the segment.

Regional Insight On a geographical front, the United States enjoys the leading position, holding the majority of the generic drugs market share.

Regional Segmentation

North America

Europ e

Asia- Pacific

Latin America

Middle East and Africa

Market Segmentation

Report Description

This can be accredited to the rising cases of chronic diseases on account of sedentary lifestyles and poor eating habits of the population. Further, physicians and pharmacists in the United States are provided with incentives for prescribing generic drugs, which has stimulated the market growth. The United States is followed by China, Brazil, Germany, France, India, the United Kingdom, Japan, Canada and Italy.

The global generic drugs market is fragmented in nature with the presence of various small and large players currently competing in terms of quality and prices. Some of the key global players operating in this market include Teva Pharmaceuticals, Mylan, Novartis, Pfizer, Sun Pharma, Fresenius, Lupin, Endo Pharma, Aurbindo Pharma and Aspen Pharmacare.

About IMARC Group: IMARC Group is a leading market research and consulting company that offers management strategy and market research worldwide. The company has done multiple projects on the generic drugs industry, which has enabled the clients to successfully set up and expand their businesses. Some of the company’s offerings include: • •

Market Research Plant setup

Market Segmentation

Report Description • • • •

Plant Expansion Marketing and sales Procurement and Distribution Innovation and Product Development

Team Profile

Team Profile Our Team Comes From Some of the Top Universities Globally.

60% Engineering and Science

5% Others

35% Business Studies

Over 2000 Independent Consultants from different sectors.

Average Experience of 7+ Years

We are the trusted business partners to the

Partial List of Clients world's leading corporates, governments, and A partial List of our Clients institutions

We are the trusted business partners to the

Partial Listworld's of Clients leading corporates, governments, and

A partial List of our Clients

institutions

Report Description and Highlights

Report Description

© 2018 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com